Shingles Research Today is a free monthly online journal that collates and summarizes the latest research about Shingles, including details on symptoms, treatment, causes, virus.

Volume 7 (2011), Issue 3 (March)

1. Herpes zoster.
   Ann Intern Med, 154(5): ITC31. [Abstract] [Full-text]
2. Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study.
   Arthritis Res Ther, 13(2): R36. [Abstract] [Full-text]
3. Effect of a single dose of pregabalin on herpes zoster pain.
   Trials, 12(1): 55. [Abstract] [Full-text]
4. Herpes zoster.
   Ann Intern Med, 154(5): ITC31. [Abstract] [Full-text]
5. Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study.
   Arthritis Res Ther, 13(2): R36. [Abstract] [Full-text]
6. Herpes zoster.
   Ann Intern Med, 154(5): ITC31. [Abstract] [Full-text]
7. Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study.
   Arthritis Res Ther, 13(2): R36. [Abstract] [Full-text]
8. Low-dose Acyclovir is Effective for Prevention of Herpes Zoster in Myeloma Patients Treated with Bortezomib: A Report from the Korean Multiple Myeloma Working Party (KMMWP) Retrospective Study.
   Jpn J Clin Oncol, 41(3): 353-7. [Abstract] [Full-text]
9. Low-dose Acyclovir is Effective for Prevention of Herpes Zoster in Myeloma Patients Treated with Bortezomib: A Report from the Korean Multiple Myeloma Working Party (KMMWP) Retrospective Study.
   Jpn J Clin Oncol, 41(3): 353-7. [Abstract] [Full-text]
10. Low-dose Acyclovir is Effective for Prevention of Herpes Zoster in Myeloma Patients Treated with Bortezomib: A Report from the Korean Multiple Myeloma Working Party (KMMWP) Retrospective Study.
    Jpn J Clin Oncol, 41(3): 353-7. [Abstract] [Full-text]
11. A 13-Year Retrospective Review of Polymerase Chain Reaction Testing for Infectious Agents from Ocular Samples.
    Ophthalmology. [Abstract] [Full-text]
12. A 13-Year Retrospective Review of Polymerase Chain Reaction Testing for Infectious Agents from Ocular Samples.
    Ophthalmology. [Abstract] [Full-text]
13. Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet.
    Med Microbiol Immunol. [Abstract] [Full-text]
14. Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet.
    Med Microbiol Immunol. [Abstract] [Full-text]
15. Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry.
    Ann Rheum Dis, 70(4): 616-623. [Abstract] [Full-text]
16. Risk of herpes zoster among patients with psychiatric diseases: a population-based study.
    J Eur Acad Dermatol Venereol, 25(4): 447-53. [Abstract] [Full-text]
17. Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet.
    Med Microbiol Immunol. [Abstract] [Full-text]
18. Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry.
    Ann Rheum Dis, 70(4): 616-23. [Abstract] [Full-text]
19. Risk of herpes zoster among patients with psychiatric diseases: a population-based study.
    J Eur Acad Dermatol Venereol, 25(4): 447-53. [Abstract] [Full-text]
20. Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry.
    Ann Rheum Dis, 70(4): 616-23. [Abstract] [Full-text]
21. Risk of herpes zoster among patients with psychiatric diseases: a population-based study.
    J Eur Acad Dermatol Venereol, 25(4): 447-53. [Abstract] [Full-text]
22. Immune reconstitution of B-cell lymphoma patients receiving CHOP-based chemotherapy containing rituximab.
    Hematol Oncol, 29(1): 5-9. [Abstract] [Full-text]
23. Immune reconstitution of B-cell lymphoma patients receiving CHOP-based chemotherapy containing rituximab.
    Hematol Oncol, 29(1): 5-9. [Abstract] [Full-text]
24. Major depressive disorder and immunity to varicella-zoster virus in the elderly.
    Brain Behav Immun. [Abstract] [Full-text]
25. Varicella-Zoster virus infection triggers formation of an IL-1{beta} processing inflammasome complex.
    J Biol Chem. [Abstract] [Full-text]
26. Varicella-Zoster virus infection triggers formation of an IL-1{beta} processing inflammasome complex.
    J Biol Chem. [Abstract] [Full-text]
27. Varicella-Zoster virus infection triggers formation of an IL-1{beta} processing inflammasome complex.
    J Biol Chem. [Abstract] [Full-text]
28. Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis.
    Adv Ther. [Abstract] [Full-text]
29. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
    Vaccine, 29(13): 2411-20. [Abstract] [Full-text]
30. Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis.
    Adv Ther. [Abstract] [Full-text]
31. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
    Vaccine, 29(13): 2411-20. [Abstract] [Full-text]
32. Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis.
    Adv Ther. [Abstract] [Full-text]
33. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
    Vaccine, 29(13): 2411-20. [Abstract] [Full-text]
34. Skin diseases following a Christmas tree pattern.
    Clin Dermatol, 29(2): 189-94. [Abstract] [Full-text]
35. Facial herpes zoster complicated by varicella zoster virus (VZV) encephalitis: The diagnostic significance of atypical lymphocytes in cerebrospinal fluid (CSF).
    Heart Lung, 40(2): 164-7. [Abstract] [Full-text]
36. Skin diseases following a Christmas tree pattern.
    Clin Dermatol, 29(2): 189-94. [Abstract] [Full-text]
37. Facial herpes zoster complicated by varicella zoster virus (VZV) encephalitis: The diagnostic significance of atypical lymphocytes in cerebrospinal fluid (CSF).
    Heart Lung, 40(2): 164-7. [Abstract] [Full-text]
38. The Immunogenicity and Safety of Live Attenuated Varicella-zoster Virus Vaccine in Human Immunodeficiency Virus-infected Children.
    Pediatr Infect Dis J, 30(4): 320-4. [Abstract] [Full-text]
39. The Immunogenicity and Safety of Live Attenuated Varicella-zoster Virus Vaccine in Human Immunodeficiency Virus-infected Children.
    Pediatr Infect Dis J, 30(4): 320-4. [Abstract] [Full-text]
40. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children.
    Pediatr Infect Dis J, 30(4): 320-4. [Abstract] [Full-text]
41. Vaccination for preventing postherpetic neuralgia.
    Cochrane Database Syst Rev, 3: CD007795. [Abstract] [Full-text]
42. Vaccines for prophylaxis of viral infections in patients with hematological malignancies.
    Cochrane Database Syst Rev, 3: CD006505. [Abstract] [Full-text]
43. Genotype of Varicella-Zoster Virus Isolates in South Korea.
    J Clin Microbiol. [Abstract] [Full-text]
44. Effect of a single dose of pregabalin on herpes zoster pain.
    Trials, 12: 55. [Abstract] [Full-text]
45. Vaccination for preventing postherpetic neuralgia.
    Cochrane Database Syst Rev, 3: CD007795. [Abstract] [Full-text]
46. Vaccines for prophylaxis of viral infections in patients with hematological malignancies.
    Cochrane Database Syst Rev, 3: CD006505. [Abstract] [Full-text]
47. Genotype of Varicella-Zoster Virus Isolates in South Korea.
    J Clin Microbiol. [Abstract] [Full-text]
48. Effect of a single dose of pregabalin on herpes zoster pain.
    Trials, 12: 55. [Abstract] [Full-text]
49. Vaccination for preventing postherpetic neuralgia.
    Cochrane Database Syst Rev, 3: CD007795. [Abstract] [Full-text]
50. Vaccines for prophylaxis of viral infections in patients with hematological malignancies.
    Cochrane Database Syst Rev, 3: CD006505. [Abstract] [Full-text]
51. Genotype of Varicella-Zoster Virus Isolates in South Korea.
    J Clin Microbiol. [Abstract] [Full-text]
52. Viral etiology of aseptic meningitis among children in southern Iran.
    J Med Virol, 83(5): 884-8. [Abstract] [Full-text]
53. Viral etiology of aseptic meningitis among children in southern Iran.
    J Med Virol, 83(5): 884-8. [Abstract] [Full-text]
54. Measuring herpes zoster, zoster-associated pain, post-herpetic neuralgia-associated loss of quality of life, and healthcare utilization and costs in Thailand.
    Int J Dermatol, 50(4): 428-435. [Abstract] [Full-text]
55. A boy with a one-sided red rash.
    Eur J Pediatr, 170(4): 539-40. [Abstract] [Full-text]
56. Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis.
    Rheumatol Int, 31(4): 481-4. [Abstract] [Full-text]
57. Measuring herpes zoster, zoster-associated pain, post-herpetic neuralgia-associated loss of quality of life, and healthcare utilization and costs in Thailand.
    Int J Dermatol, 50(4): 428-435. [Abstract] [Full-text]
58. A boy with a one-sided red rash.
    Eur J Pediatr, 170(4): 539-40. [Abstract] [Full-text]
59. Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis.
    Rheumatol Int, 31(4): 481-4. [Abstract] [Full-text]
60. Measuring herpes zoster, zoster-associated pain, post-herpetic neuralgia-associated loss of quality of life, and healthcare utilization and costs in Thailand.
    Int J Dermatol, 50(4): 428-35. [Abstract] [Full-text]
61. A boy with a one-sided red rash.
    Eur J Pediatr, 170(4): 539-40. [Abstract] [Full-text]
62. Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis.
    Rheumatol Int, 31(4): 481-4. [Abstract] [Full-text]
63. Subclinical reactivation of varicella zoster virus in all stages of HIV infection.
    J Neurol Sci. [Abstract] [Full-text]
64. Varicella-Zoster Virus-Specific Cell-Mediated Immune Reponses in HIV-infected Adults.
    AIDS Res Hum Retroviruses. [Abstract] [Full-text]
65. Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study.
    CMAJ, 183(5): E275-80. [Abstract] [Full-text]
66. Varicella-Zoster Virus-Specific Cell-Mediated Immune Reponses in HIV-infected Adults.
    AIDS Res Hum Retroviruses. [Abstract] [Full-text]
67. Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study.
    CMAJ, 183(5): E275-80. [Abstract] [Full-text]
68. Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study.
    CMAJ, 183(5): E275-80. [Abstract] [Full-text]
69. Prevalence of dermatological disorders in Japan: A nationwide, cross-sectional, seasonal, multicenter, hospital-based study.
    J Dermatol, 38(4): 353-63. [Abstract] [Full-text]
70. Varicella reinfection in a seropositive physician following occupational exposure to localized zoster.
    Clin Infect Dis, 52(7): 907-9. [Abstract] [Full-text]
71. Prevalence of dermatological disorders in Japan: A nationwide, cross-sectional, seasonal, multicenter, hospital-based study.
    J Dermatol, 38(4): 353-63. [Abstract] [Full-text]
72. Varicella reinfection in a seropositive physician following occupational exposure to localized zoster.
    Clin Infect Dis, 52(7): 907-9. [Abstract] [Full-text]
73. Prevalence of dermatological disorders in Japan: A nationwide, cross-sectional, seasonal, multicenter, hospital-based study.
    J Dermatol, 38(4): 353-63. [Abstract] [Full-text]
74. Varicella reinfection in a seropositive physician following occupational exposure to localized zoster.
    Clin Infect Dis, 52(7): 907-9. [Abstract] [Full-text]
75. Koebner's phenomenon in systemic lupus erythematosus.
    Rheumatol Int. [Abstract] [Full-text]
76. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
    Vaccine. [Abstract] [Full-text]
77. Koebner's phenomenon in systemic lupus erythematosus.
    Rheumatol Int. [Abstract] [Full-text]
78. Koebner's phenomenon in systemic lupus erythematosus.
    Rheumatol Int. [Abstract] [Full-text]
79. Mechanisms of Viral Infections Associated with HIV: Workshop 2B.
    Adv Dent Res, 23(1): 130-6. [Abstract] [Full-text]
80. Is cupping an effective treatment? An overview of systematic reviews.
    J Acupunct Meridian Stud, 4(1): 1-4. [Abstract] [Full-text]
81. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy.
    Transplant Proc, 43(2): 466-8. [Abstract] [Full-text]
82. Mechanisms of Viral Infections Associated with HIV: Workshop 2B.
    Adv Dent Res, 23(1): 130-6. [Abstract] [Full-text]
83. Mechanisms of Viral Infections Associated with HIV: Workshop 2B.
    Adv Dent Res, 23(1): 130-6. [Abstract] [Full-text]
84. Pharmacokinetics and Safety of FV-100, a Novel Oral Anti-Herpes Zoster Nucleoside Analogue, Administered in Single and Multiple Doses to Healthy Young Adult and Elderly Adult Volunteers.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
85. Pharmacokinetics and Safety of FV-100, a Novel Oral Anti-Herpes Zoster Nucleoside Analogue, Administered in Single and Multiple Doses to Healthy Young Adult and Elderly Adult Volunteers.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
86. Pharmacokinetics and Safety of FV-100, a Novel Oral Anti-Herpes Zoster Nucleoside Analogue, Administered in Single and Multiple Doses to Healthy Young Adult and Elderly Adult Volunteers.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
87. Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents.
    Viral Immunol, 24(2): 151-7. [Abstract] [Full-text]
88. Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents.
    Viral Immunol, 24(2): 151-7. [Abstract] [Full-text]
89. Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents.
    Viral Immunol, 24(2): 151-7. [Abstract] [Full-text]

© 2005-2011 Shingles Research Today. All Rights Reserved.